UK scientists propose that patients diagnosed with bowel cancer undergo a few chemotherapy sessions before undergoing surgery to remove the tumor.

A study published on Thursday (19/1) in the Journal of Clinical Oncology, shows that this change in treatment strategy can reduce the risk of the disease returning in the following two years by about 28%. The standard approach adopted is surgery followed by chemotherapy.

Study

Made by scientists from the universities of Birmingham and Leeds, both in England, the research analyzed data from 1,053 patients with bowel cancer from 85 hospitals in the United Kingdom, Denmark and Sweden.

Participants were divided into two groups. The first, with 699 people, underwent six weeks of chemotherapy before having surgery, followed by another 18 weeks of chemotherapy. The second group, meanwhile, had the standard treatment for bowel cancer, with surgery followed by 24 weeks of chemotherapy.

Advertising by Metrópoles 1 partner
Advertising by Metrópoles 2 partner
Advertising by Metrópoles 3 partner
Advertising by Metrópoles 4 partner
Advertising by Metrópoles 5 partner

0

Those who received chemotherapy before surgery were significantly less likely to be re-diagnosed within the next two years compared with others.

“Timing is everything when it comes to treating colon cancer. The simple act of anticipating chemotherapy, administering it before and not after surgery, produces some remarkable results”, pointed out Professor Matthew Seymour, who participated in the research.

Get news from metropolises on your Telegram and stay on top of everything! Just access the channel: https://t.me/metropolesurgente.

California18

Welcome to California18, your number one source for Breaking News from the World. We’re dedicated to giving you the very best of News.

Leave a Reply